Photocure ASA (PHCUF) has released an update.
Photocure ASA is set to release its Q2 and first half 2024 financial results on August 7, 2024, followed by a live webcast presentation by CEO Dan Schneider and CFO Erik Dahl. The presentation, which will cover the company’s performance and be open to questions, can be accessed via a provided link. Photocure, known for its innovative technology in the bladder cancer space, is based in Oslo and traded on the OSE.
For further insights into PHCUF stock, check out TipRanks’ Stock Analysis page.
